Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Perfluoroalkyl substances (PFAS) can act as surfactants and have been suggested to be capable of affecting gut mucosa integrity, a possible factor in the pathogenesis of inflammatory bowel disease (IBD). So far, only PFOA has been shown to have a positive association with ulcerative colitis. The present study aimed to investigate the association of PFAS and clinically diagnosed IBD in the Ronneby cohort, a population with high PFAS exposure (especially high PFOS and PFHxS) from Aqueous Film-Forming Foam through drinking water, using registry data. Additionally, to explore associations of PFAS with fecal zonulin and calprotectin, subclinical biomarkers of gut inflammation and permeability, in a sub-set of participants from Ronneby and Karlshamn (a nearby control municipality). The registry study included all people that ever resided in Ronneby municipality at least one year between 1980 and 2013. Yearly exposure to contaminated drinking water was assessed based on residential addresses and waterworks supply data, and the population classified by early, mid and late periods in ascending level of contamination. Diagnosed IBD cases were retrieved from the Swedish National Patient register and cause-of-death register. The Cox proportional hazards model was used to derive the hazard ratios (HRs) for diagnosed IBD. The biomarker study included 189 individuals who provided fecal samples. Serum PFAS were measured using LC-MS/MS. Fecal zonulin and calprotectin were measured using ELISA. Linear regression was used to assess the associations between measured PFAS and biomarker levels. In the registry study, no raised HRs for diagnosed IBD were found for cohort subjects with mid (1995-2004) or late period (2005-2013) exposure compared to never exposure. Early period exposure only (1985-1994) showed raised HRs for Crohn's disease (HR = 1.58, p = 0.048) and other non-specified IBD (HR = 1.38, p = 0.037). In the biomarker study, Karlshamn showed higher fecal calprotectin levels (median = 99.6 mg/kg in Karlshamn vs. 66.8 mg/kg in Ronneby, p = 0.04). A trend of decreased calprotectin with increased serum PFAS indicated higher PFAS was associated with lower degree of gut inflammation (p = 0.002). No association between serum PFAS and fecal zonulin was found. In conclusion, the present study found no consistent evidence to support PFAS exposure as a risk factor for IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, X. C., Andrews, D. Q., Lindstrom, A. B., Bruton, T. A., Schaider, L. A., Grandjean, P., Lohmann, R., Carignan, C. C., Blum, A., Balan, S. A., et al. (2016) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6b00260 · Cited by 1,333
Half-Lives of PFOS, PFHxS and PFOA after End of Exposure to Contaminated Drinking Water
Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C. H., Tallving, P., & Jakobsson, K. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104651 · Cited by 815
Self-citationIntestinal permeability and its regulation by zonulin: Diagnostic and therapeutic implications
Fasano, A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.012 · Cited by 402
Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., Nielsen, K. R., Brassard, P., Vutcovici, M., Bitton, A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.043 · Cited by 286
Guelfo, J. L., & Adamson, D. T. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.01.066 · Cited by 216
Research works printed but not linked: 32
- Andersson, 2019, High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohot study from Ronneby, Sweden, Environ. Res., 176, 108540, 10.1016/j.envres.2019.108540 · DOI · Paper page
- Chiba, 2008, Transmembrane proteins of tight junctions, Biochim. Biophys. Acta Biomembr., 1778, 588, 10.1016/j.bbamem.2007.08.017 · DOI · Paper page
- Csáki, 2011, Synthetic surfactant food additives can cause intestinal barrier dysfunction, Med. Hypotheses, 76, 676, 10.1016/j.mehy.2011.01.030 · DOI
- Dahlhamer, 2016, Prevalence of inflammatory bowel disease among adults aged ≥18 years-United States, MMWR Morb. Mortal. Wkly. Rep., 65, 1166, 10.15585/mmwr.mm6542a3 · DOI · Paper page
- Dolan, 2017, Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases, Mol. Nutr. Food Res., 61, 1600129, 10.1002/mnfr.201600129 · DOI · Paper page
- Domingo, 2012, Health risks of dietary exposure to perfluorinated compounds, Environ. Int., 40, 187, 10.1016/j.envint.2011.08.001 · DOI · Paper page
- Ehrchen, 2009, The endogenous toll–like receptor 4 agonist s100a8/s100a9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer, J. Leukoc. Biol., 86, 557, 10.1189/jlb.1008647 · DOI · Paper page
- Erbayrak, 2009, The role of fecal calprotectin in investigating inflammatory bowel diseases, Clinics, 64, 421, 10.1590/S1807-59322009000500009 · doi:10.1590/s1807-59322009000500009
- Eriksson, 2013, Perfluoroalkyl substances (pfass) in food and water from Faroe Islands, Environ. Sci. Pollut. Res. Int., 20, 7940, 10.1007/s11356-013-1700-3 · DOI
- Eue, 2000, Transendothelial migration of 27e10+ human monocytes, Int. Immunol., 12, 1593, 10.1093/intimm/12.11.1593 · DOI
- European Food Safety Authority, 2018, vol. 16
- Hou, 2013, The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study, Inflamm. Bowel Dis., 19, 1059, 10.1097/MIB.0b013e31828028ca · DOI
- Katzka, 2014, Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis, Clin. Gastroenterol. Hepatol., 12, 1824, 10.1016/j.cgh.2014.02.039 · DOI
- Lapidus, 2006, Crohn's disease in stockholm county during 1990-2001: an epidemiological update, World J. Gastroenterol., 12, 75, 10.3748/wjg.v12.i1.75 · DOI · Paper page
- Ludvigsson, 2017, Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study, BMC Gastroenterol., 17, 23, 10.1186/s12876-017-0578-9 · DOI · Paper page
- Mahid, 2006, Smoking and inflammatory bowel disease: a meta-analysis, Mayo Clin. Proc., 81, 1462, 10.4065/81.11.1462 · DOI · Paper page
- Malíčková, 2017, Fecal zonulin is elevated in crohn's disease and in cigarette smokers, Pract Lab Med, 9, 39, 10.1016/j.plabm.2017.09.001 · DOI · Paper page
- Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 · DOI · Paper page
- Odink, 1987, Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis, Nature, 330, 80, 10.1038/330080a0 · DOI · Paper page
- Ohlsson, 2017, Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents, Biomed Rep, 6, 411, 10.3892/br.2017.865 · DOI · Paper page
- Poullis, 2003, Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity, Eur. J. Gastroenterol. Hepatol., 15, 573, 10.1097/00042737-200305000-00021 · DOI · Paper page
- Rönnblom, 2010, Ulcerative colitis in the county of uppsala 1945–2007: incidence and clinical characteristics, J Crohns Colitis, 4, 532, 10.1016/j.crohns.2010.03.003 · DOI
- Sapone, 2006, Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives, Diabetes, 55, 1443, 10.2337/db05-1593 · DOI · Paper page
- Scheffler, 2018, Widely used commercial elisa does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family., Front Endocrinol, 9
- Steenland, 2013, Ulcerative colitis and perfluorooctanoic acid (pfoa) in a highly exposed population of community residents and workers in the mid-Ohio valley, Environ. Health Perspect., 121, 900, 10.1289/ehp.1206449 · DOI · Paper page
- Steenland, 2015, A cohort incidence study of workers exposed to perfluorooctanoic acid (pfoa), Occup. Environ. Med., 72, 373, 10.1136/oemed-2014-102364 · DOI · Paper page
- Steenland, 2018, Pfoa and ulcerative colitis, Environ. Res., 165, 317, 10.1016/j.envres.2018.05.007 · DOI · Paper page
- Uniken Venema, 2017, The genetic background of inflammatory bowel disease: from correlation to causality, J. Pathol., 241, 146, 10.1002/path.4817 · DOI
- Vanuytsel, 2013, The role of haptoglobin and its related protein, zonulin, in inflammatory bowel disease, Tissue Barriers, 1, 10.4161/tisb.27321 · DOI · Paper page
- Walsham, 2016, Fecal calprotectin in inflammatory bowel disease, Clin. Exp. Gastroenterol., 9, 21
- Żak-Gołąb, 2013, Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects, Internet J. Endocrinol., 2013, 674106
- Zwadlo, 1988, Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues, Clin. Exp. Immunol., 72, 510
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Podder, A., Sadmani, A. H. M. A., Reinhart, D., Chang, N.-B., & Goel, R. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126361 · Cited by 623
PFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies
India-Aldana, S., Yao, M., Midya, V., Colicino, E., Chatzi, L., Chu, J., Gennings, C., Jones, D. P., Loos, R. J. F., Setiawan, V. W., et al. (2023) · Current Pollution Reports · doi:10.1007/s40726-023-00269-4 · Cited by 114
Metadata
- Authors
- Xu, Y., Li, Y., Scott, K., Lindh, C. H., Jakobsson, K., Fletcher, T., Ohlsson, B., & Andersson, E. M.
- Venue
- Environmental Research
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 181
- Pages
- 108923
- ISSN
- 0013-9351 (ISSN-L)
- OpenAlex
- W2985497314
- Cited by
- 72
- References
- 5
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Svenska Forskningsrådet Formas (216-2014-1709)
- Lunds Universitet
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2015-732)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. https://app.cochat.ai/papers/10.1016/j.envres.2019.108923
- The paper
- Xu, Y., Li, Y., Scott, K., Lindh, C. H., Jakobsson, K., Fletcher, T., Ohlsson, B., & Andersson, E. M. (2020). Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environmental Research. https://doi.org/10.1016/j.envres.2019.108923
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.